SAN DIEGO, Jan 29, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- BioMed Realty Trust, Inc.
(NYSE: BMR) today announced it will report results for its fourth quarter and
year ended December 31, 2007 after the market closes on Thursday, February 28,
Alan D. Gold, President and Chief Executive Officer, and Kent Griffin,
Chief Financial Officer, will host an investor conference call at 10:00 a.m.
Pacific Time on Friday, February 29, 2008 to discuss the company's financial
results and operations for the year.
The call will be open to all interested investors either through a live
audio web cast at the Investor Relations section of the company's web site at
www.biomedrealty.com and www.earnings.com, or live by calling (800) 706-7748
(domestic) or (617) 614-3473 (international) with call ID number 26368280.
The call will be archived for 30 days on both web sites. A telephone playback
of the conference call will also be available from 3:00 p.m. Pacific Time on
Friday, February 29, 2008 through midnight Pacific Time on Wednesday, March 5,
2008 by calling (888) 286-8010 (domestic) or (617) 801-6888 (international)
and using access code 93044857.
About BioMed Realty Trust
BioMed Realty Trust, Inc. is a real estate investment trust (REIT) focused
on Providing Real Estate to the Life Science Industry(R). The company's
tenants primarily include biotechnology and pharmaceutical companies,
scientific research institutions, government agencies and other entities
involved in the life science industry. BioMed Realty Trust owns or has
interests in 68 properties, representing 104 buildings with approximately 8.5
million rentable square feet, as well as approximately 1.9 million square feet
of development in progress. These properties are located predominantly in the
major U.S. life science markets of Boston, San Diego, San Francisco, Seattle,
Maryland, Pennsylvania and New York/New Jersey, which have well-established
reputations as centers for scientific research. Additional information is
available at www.biomedrealty.com.
SOURCE BioMed Realty Trust, Inc.